Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth S Koeneman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
BJU International|June 26, 2004
Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomySeyed M Khoddami, Shahrokh F Shariat, Yair Lotan, et al.
The Prostate|January 1, 2010
Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancerYingming Li, Bahaa S Malaeb, Zhong-Ze Li, et al.
The Journal of Urology|May 6, 2004
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomyYair Lotan, Shahrokh F Shariat, Seyed M Khoddami, et al.
Urologic Oncology|July 14, 2007
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohortsBahaa S Malaeb, Hani H Rashid, Yair Lotan, et al.
The Journal of Urology|February 10, 2004
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomyShahrokh F Shariat, Seyed M Khoddami, Hossein Saboorian, et al.
Urologic Oncology|March 8, 2006
Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer modelBenjamin K Canales, Yingming Li, Melissa G Thompson, et al.
Urologic Oncology|May 11, 2010
Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line modelsYingming Li, Robert A Sikes, Bahaa S Malaeb, et al.
International Journal of Cancer|May 4, 2004
Cellular interactions in the tropism of prostate cancer to boneRobert A Sikes, Brian E Nicholson, Kenneth S Koeneman, et al.
Human Gene Therapy|March 18, 2003
Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancerHiroyuki Kubo, Thomas A Gardner, Yoshitaka Wada, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
BJU International|June 26, 2004
Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomySeyed M Khoddami, Shahrokh F Shariat, Yair Lotan, et al.
The Prostate|January 1, 2010
Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancerYingming Li, Bahaa S Malaeb, Zhong-Ze Li, et al.
The Journal of Urology|May 6, 2004
The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomyYair Lotan, Shahrokh F Shariat, Seyed M Khoddami, et al.
Urologic Oncology|July 14, 2007
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohortsBahaa S Malaeb, Hani H Rashid, Yair Lotan, et al.
The Journal of Urology|February 10, 2004
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomyShahrokh F Shariat, Seyed M Khoddami, Hossein Saboorian, et al.
Urologic Oncology|March 8, 2006
Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer modelBenjamin K Canales, Yingming Li, Melissa G Thompson, et al.
Urologic Oncology|May 11, 2010
Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line modelsYingming Li, Robert A Sikes, Bahaa S Malaeb, et al.
International Journal of Cancer|May 4, 2004
Cellular interactions in the tropism of prostate cancer to boneRobert A Sikes, Brian E Nicholson, Kenneth S Koeneman, et al.
Human Gene Therapy|March 18, 2003
Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancerHiroyuki Kubo, Thomas A Gardner, Yoshitaka Wada, et al.
Pageof 3